Psychedelic Business Spotlight – June 3
This week in psychedelic business news: Cybin moves towards clinical trials; Braxia releases data on treating depression with psilocybin; Clearmind files for a new patent; and much more!
Author: James Hallifax
Does MDMA Reduce Fear? New Study Has Implications for PTSD Treatment
Using a measurement tool called the SCR, researchers found that combining MDMA with fear extinction learning and recall therapy significantly reduced the fear felt by study participants, as compared to the placebo. This may have big implications for how we treat PTSD.
British Columbia to Decriminalize Possession of Most Drugs
Those caught with under 2.5 grams of illicit drugs, including heroin and fentanyl, will not face jail time when the regulations go into effect.
5 Next-Generation Psychedelics Entering Clinical Trials This Year
Modernized psychedelic medicine is coming, whether you like it or not, so here are five of the most exciting next-generation psychedelics on the horizon.
How to Microdose Psilocybin According to Paul Stamets: The Stamets Stack
Famed mycologist Paul Stamets recommends the Stamets Stack when microdosing psilocybin. Here’s how he plans and measures doses.
Psychedelic Medicine Has Institutional Buy-In & 4 More Catalyst Summit Takeaways
After leaving the Catalyst Summit, I am more confident than ever in the governmental and regulatory pathways for legal psychedelic medicine.
Senator’s Wife Secretly Gave Him Psilocybin to Alleviate Depression
Senator Larry Campbell, who struggles with depression, PTSD, and “getting old,” reveals that psilocybin microdoses helped improve his mood.
Psychedelic Capitalism Takes a Trip to Davos
From May 21-26, for the first time, the Davos Forum will feature The House of Psychedelics. Here’s why that matters for the psychedelics industry.
Comparing MindMed, Atai Life Sciences, Compass Pathways: A Psychedelic Stock Analysis
Our resident psychedelic investor explains a handful of important metrics to study when analyzing and comparing psychedelic stocks.
A Brief History of MDMA: From the CIA to Raves to Psychedelic Therapy
The history of MDMA is fascinating, and it is still being written.
End of content
End of content